Envoy Medical, Inc.
Close on Oct 19, 2026
- Market cap
- $68.04M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Next report expected Nov 9, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 10, 2026 | After market close | $51.00K | $-0.07 | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 11, 2026 | Before market open | $39.00K | – | – |
| Q4 FY2025 Ended Dec 31, 2025 | Mar 27, 2026 | After market close | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 10, 2025 | Before market open | $42.00K | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Jul 31, 2025 | Before market open | $78.00K | $-0.32 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 1, 2025 | After market close | – | – | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 14, 2024 | Before market open | $56.00K | $-0.37 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 12, 2024 | Before market open | $68.00K | $-0.27 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 15, 2024 | After market close | $59.00K | $-0.32 | – |
Press releases
Announcements Envoy Medical filed with the SEC
PRESS RELEASE DATED AUGUST 10, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 11, 2026
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 23, 2026
Results of operations · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED FEBRUARY 24, 2026
Listing notice · Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED FEBRUARY 12, 2026
Material agreement · Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION DECEMBER 2025 www.envoymedical.com NASDAQ: COCH Hear for Life
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 10, 2025
Results of operations · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED OCTOBER 27, 2025
Listing notice · Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED OCTOBER 8, 2025
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED OCTOBER 7, 2025
Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED SEPTEMBER 22, 2025.
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED SEPTEMBER 19, 2025
Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED JULY 31, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MAY 1, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED MARCH 31, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED NOVEMBER 14, 2024
Results of operations · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED AUGUST 28, 2024
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED AUGUST 12, 2024
Results of operations · EX-99.1 to Form 8-K
ENVOY MEDICAL, INC. PRESS RELEASE, DATED JULY 31, 2024
Other events · EX-99.1 to Form 8-K
INVESTOR PRESENTATION July 2024 www.envoymedical.com NASDAQ: COCH Hear for Life
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED JUNE 11, 2024
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE DATED MAY 15, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED OCTOBER 10, 2023
Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL CORPORATION AND ANZU SPECIAL ACQUISITION
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Corp I Stockholders Approve Business Combination with Envoy Medical Corporation
Shareholder vote results · Regulation FD disclosure · EX-99.1 to Form 8-K
ENVOY MEDICAL | 1 Investor Presentation Hear for Life September 2023
Other events · EX-99.1 to Form 8-K
ENVOY MEDICAL | 1 Investor Presentation Hear for Life
Other events · EX-99.1 to Form 8-K
Anzu Special Acquisition Corp I Announces Adjournment
Regulation FD disclosure · EX-99.1 to Form 8-K
Anzu Special Acquisition Corp I Announces Adjournment
Regulation FD disclosure · EX-99.1 to Form 8-K
ENVOY MEDICAL | 1 Investor Presentation Hear for Life
Other events · EX-99.1 to Form 8-K
Anzu Special Acquisition Corp I Announces Forward Purchase Agreements
Material agreement · Unregistered share sale · Regulation FD disclosure · EX-99.1 to Form 8-K